Appearance:
White or off-white powder
Molecular Weight:
429.9
Density:
g/cm3
Boiling Point:
553.6 °C at 760 mmHg
Melting Point:
223-225°C
Flash Point:
288.6 °C
Usage:
Erlotinib hydrochloride (CAS NO.183319-69-9) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer.
*The following content is generated by AI and is for reference only.
Overview
Erlotinib hydrochloride is a potent, small-molecule tyrosine kinase inhibitor targeting EGFR. Synthesized via multi-step organic reactions, its molecular formula is C22H23ClN4O·HCl with CAS 183321-74-6.
Application
- Oncology Manufacturing: Production of non-small cell lung cancer (NSCLC) therapeutics.
- Pharmaceutical R&D: Clinical trial supply for targeted therapy research.
- Diagnostics: Reagent development for EGFR mutation detection kits.
Precautions
Restricted to prescription use only; avoid exposure in pregnant personnel. Store at 2°C–8°C in dry, light-resistant containers to maintain chemical stability.